GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (FRA:2LQ) » Definitions » Other Net Income (Loss)

Elixxer (FRA:2LQ) Other Net Income (Loss) : €-0.06 Mil (TTM As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Elixxer Other Net Income (Loss)?

Elixxer's Other Net Income (Loss) for the three months ended in Sep. 2023 was €0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.06 Mil.

Elixxer's annual Other Net Income (Loss) declined from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€-0.03 Mil) and declined from Dec. 2021 (€-0.03 Mil) to Dec. 2022 (€-0.06 Mil).


Elixxer Other Net Income (Loss) Historical Data

The historical data trend for Elixxer's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer Other Net Income (Loss) Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.03 -0.06

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.06 - - -

Elixxer Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixxer Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Elixxer's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixxer (FRA:2LQ) Business Description

Traded in Other Exchanges
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.

Elixxer (FRA:2LQ) Headlines

No Headlines